课题基金 / 基金详情

HOMOCYSTEINE AND PROGRESSION OF ATHEROSCLEROSIS

HOMOCYSTEINE AND PROGRESSION OF ATHEROSCLEROSIS
同型半胱氨酸与动脉粥样硬化的进展
批准号：
6116921
负责人：
JOHN M PORTER
金额：
$3.13万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6116921
关键词：
atherosclerosis blood chemistry cardiovascular disorder chemotherapy cerebrovascular disorders clinical research folate homocysteine human subject human therapy evaluation longitudinal human study pathologic process peripheral blood vessel

项目摘要

项目成果

JOHN M PORTER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a prospective clinical study designed to evaluate the rate of progression of atherosclerotic lower extremity (LED) and cerebrovascular (CVD) disease in a population of patients with LED and/or CVD. The study will examine the relationships between progression of atherosclerosis, level of plasma homocysteine (HC), and treatment to lower plasma HC (folic acid) in patients. The study will occupy eight years.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOSE RESPONSE EVALUATION OF ILOPROST IN TREATMENT OF CLAUDICATION
INTRAVENOUS AS 013 FOR TREATMENT OF SEVERE LIMB ISCHEMIA
DOSE RESPONSE EVALUATION OF ILOPROST IN TREATMENT OF CLAUDICATION
INTRAVENOUS AS 013 FOR TREATMENT OF SEVERE LIMB ISCHEMIA
海外基金